Literature DB >> 6930513

Extraction of a murine tumor-specific transplantation antigen with 1-butanol. I. Partial purification by isoelectric focusing.

S J LeGrue, B D Kahan, N R Pellis.   

Abstract

Treatment of whole viable MCA-F murine sarcoma cells from syngeneic female C3H/HeJ mice with a single-phase solution of 2.5% (vol/vol) 1-butanol yielded a crude membrane protein extract without loss of cell viability. 1-Butanol-extracted cells were capable of in vitro proliferation. Variations in extraction conditions significantly influenced not only protein yield but also viability. The crude butanol extract (CBE) contained a tumor-specific transplantation antigen (TSTA) more potent than that obtained by 3-M KCl extraction of MCA-F cells: a specific activity of 40 TSTA U/mg protein in the former and 2 U/mg in the latter. The antigen was specific and protected host against challenge with MCA-F cells but not the antigenically different MCA-D cells. The growth of MCA-F cells was not reduced by pretreatment with equivalent doses of CBE obtained from MCA-D cells. Partial purification of the antigenic activity by preparative isoelectric focusing revealed that most activity focused in the pH 6.4 fraction, which increased the specific activity to 1,000 TSTA U/mg protein. Thus 1-butanol was an effective agent for the extraction of certain membrane polypeptides, including an immunogenic TSTA, from whole cells.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6930513

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  12 in total

1.  Low-molecular-weight membrane component inhibits the metastatic phenotype of B16-F10 melanoma.

Authors:  Z Keren; S J LeGrue
Journal:  Clin Exp Metastasis       Date:  1989 May-Jun       Impact factor: 5.150

2.  The effect of purification on the immunogenicity of tumor-specific transplantation antigens.

Authors:  T L Saunders; B D Kahan; N R Pellis
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

3.  Selective extraction by 1-butanol of surface glycoprotein antigens from human melanoma cells.

Authors:  S K Liao; J W Smith; P C Kwong
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

4.  Purification of immunoprotective tumor antigens by preparative isotachophoresis.

Authors:  T L Saunders; B D Kahan; N R Pellis
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

Review 5.  Noncytolytic extraction of cell surface antigens using butanol.

Authors:  S J LeGrue
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

6.  Reconstituted membranes of tumour cells (proteoliposomes) induce specific protection to murine lymphoma cells.

Authors:  J J Bergers; W Den Otter; J W De Groot; A W De Blois; H F Dullens; P A Steerenberg; D J Crommelin
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

7.  Carrier and adjuvant properties of liposome-borne tumor-specific antigens.

Authors:  S J LeGrue
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

8.  Purification and biochemical properties of tumor-associated transplantation antigens from methylcholanthrene-induced murine sarcomas.

Authors:  G C DuBois; L W Law; E Appella
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

9.  Tumor rejection antigens of chemically induced sarcomas of inbred mice.

Authors:  P K Srivastava; A B DeLeo; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

10.  Immune reactivity in cattle with ocular squamous cell carcinoma after intralesional BCG immunotherapy.

Authors:  W R Klein; P A Steerenberg; F Poelma; E vd Wiel; V P Rutten; W Misdorp; W H de Jong; E J Ruitenberg
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.